Literature DB >> 27354983

Progression of Cutaneous Vitiligo in a Patient with Large Posterior Choroidal Melanoma: A Case Report.

Angela Ding1, Javier Elizalde2, Rafael Ignacio Barraquer2.   

Abstract

BACKGROUND/AIMS: The aim of our study was to report a case of progression of cutaneous vitiligo after large posterior choroidal melanoma diagnosis.
METHODS: The clinical history, fundus findings and histopathological features suggest the diagnosis of cutaneous vitiligous progression after a diagnosis of large posterior choroidal melanoma.
RESULTS: A 30-year-old female, with a personal history of cutaneous vitiligo for 12 years, was diagnosed with choroidal melanoma 18 months previously. The cutaneous vitiligo had progressed over her back, body and arms during the preceding 3 years. She refused treatment because she was in her 28th week of pregnancy. When she came to our clinic her visual symptoms had worsened, and the fundus examination showed a melanocytic choroidal mass. After confirming that there was no extraocular extension, she was treated with enucleation. A histopathological study confirmed the choroidal melanoma diagnosis.
CONCLUSION: The association between the progression of vitiligo and the diagnosis of uveal melanoma could be considered a good prognostic factor, as has been described in cases of cutaneous melanoma. A longer follow-up of these patients will allow us to confirm this association.

Entities:  

Keywords:  Choroidal melanoma; Cutaneous vitiligo; Pregnancy; Progression

Year:  2015        PMID: 27354983      PMCID: PMC4913769          DOI: 10.1159/000376622

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  10 in total

1.  Malignant melanoma of the choroid in a case of naevus of ota.

Authors:  R Frezzotti; R Guerra; G P Dragoni; P Bonanni
Journal:  Br J Ophthalmol       Date:  1968-12       Impact factor: 4.638

2.  Uveal malignant melanoma with leucoderma.

Authors:  M S Nirankari; K K Khanna; R P Mathur
Journal:  J All India Ophthalmol Soc       Date:  1968-06

3.  Vitiligo in patients with metastatic melanoma: a good prognostic sign.

Authors:  J J Nordlund; J M Kirkwood; B M Forget; G Milton; D M Albert; A B Lerner
Journal:  J Am Acad Dermatol       Date:  1983-11       Impact factor: 11.527

4.  Cutaneous vitiligo following management of uveal melanoma in 6 patients.

Authors:  Pukhraj Rishi; Carol L Shields; Kaitlin Patrick; Jerry A Shields
Journal:  JAMA Ophthalmol       Date:  2013-09       Impact factor: 7.389

5.  Ocular abnormalities associated with cutaneous melanoma and vitiligolike leukoderma.

Authors:  M A Chang; G Fournier; H K Koh; A J Sober; H Nakagawa; T B Fitzpatrick; D M Albert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

6.  Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study.

Authors:  P Quaglino; F Marenco; S Osella-Abate; N Cappello; M Ortoncelli; B Salomone; M T Fierro; P Savoia; M G Bernengo
Journal:  Ann Oncol       Date:  2009-07-21       Impact factor: 32.976

7.  Vitiligo or halo nevi occurring in two patients with choroidal melanoma.

Authors:  D M Albert; N Todes-Taylor; M Wagoner; J J Nordlund; A B Lerner
Journal:  Arch Dermatol       Date:  1982-01

8.  Prognostic significance of hypopigmentation in malignant melanoma.

Authors:  J C Bystryn; D Rigel; R J Friedman; A Kopf
Journal:  Arch Dermatol       Date:  1987-08

Review 9.  Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality?

Authors:  Maya Ram; Yehuda Shoenfeld
Journal:  Ann N Y Acad Sci       Date:  2007-09       Impact factor: 5.691

Review 10.  Vitiligo--part 1.

Authors:  Roberto Gomes Tarlé; Liliane Machado do Nascimento; Marcelo Távora Mira; Caio Cesar Silva de Castro
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.